MedKoo Cat#: 127920 | Name: BC-1215
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BC-1215 is a F-box protein 3 (Fbxo3) inhibitor. BC-1215 works by antagonizing of Fbxo3 on TRAF cytokine signaling and exhibits a low IC50 in vitro.

Chemical Structure

BC-1215
BC-1215
CAS#1507370-20-8

Theoretical Analysis

MedKoo Cat#: 127920

Name: BC-1215

CAS#: 1507370-20-8

Chemical Formula: C26H26N4

Exact Mass: 394.2157

Molecular Weight: 394.52

Elemental Analysis: C, 79.16; H, 6.64; N, 14.20

Price and Availability

Size Price Availability Quantity
25mg USD 350.00 2 Weeks
50mg USD 550.00 2 Weeks
100mg USD 950.00 2 Weeks
1g USD 4,250.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
BC-1215; BC 1215; BC1215
IUPAC/Chemical Name
N1,N2-bis(4-(pyridin-2-yl)benzyl)ethane-1,2-diamine
InChi Key
IXEPQJQQSLMESJ-UHFFFAOYSA-N
InChi Code
InChI=1S/C26H26N4/c1-3-15-29-25(5-1)23-11-7-21(8-12-23)19-27-17-18-28-20-22-9-13-24(14-10-22)26-6-2-4-16-30-26/h1-16,27-28H,17-20H2
SMILES Code
C1(CNCCNCC2=CC=C(C3=NC=CC=C3)C=C2)=CC=C(C4=NC=CC=C4)C=C1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 394.52 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Jeon S, Kang J, Lee SB. BC-1215 inhibits ATP-induced IL-1β secretion via the FBXL2-mediated ubiquitination and degradation of not only NLRP3, but also pro- IL-1β in LPS-primed THP-1 cells. Biochem Biophys Res Commun. 2023 May 21;657:128-135. doi: 10.1016/j.bbrc.2023.03.055. Epub 2023 Mar 22. PMID: 37004285. 2: Hung KY, Liao WI, Pao HP, Wu SY, Huang KL, Chu SJ. Targeting F-Box Protein Fbxo3 Attenuates Lung Injury Induced by Ischemia-Reperfusion in Rats. Front Pharmacol. 2019 May 24;10:583. doi: 10.3389/fphar.2019.00583. PMID: 31178737; PMCID: PMC6544082. 3: Gao Y, Xiao X, Luo J, Wang J, Peng Q, Zhao J, Jiang N, Zhao Y. E3 Ubiquitin Ligase FBXO3 Drives Neuroinflammation to Aggravate Cerebral Ischemia/Reperfusion Injury. Int J Mol Sci. 2022 Nov 7;23(21):13648. doi: 10.3390/ijms232113648. PMID: 36362432; PMCID: PMC9658360. 4: Hsieh MC, Ho YC, Lai CY, Wang HH, Yang PS, Cheng JK, Chen GD, Ng SC, Lee AS, Tseng KW, Lin TB, Peng HY. Blocking the Spinal Fbxo3/CARM1/K+ Channel Epigenetic Silencing Pathway as a Strategy for Neuropathic Pain Relief. Neurotherapeutics. 2021 Apr;18(2):1295-1315. doi: 10.1007/s13311-020-00977-5. Epub 2021 Jan 7. PMID: 33415686; PMCID: PMC8423947. 5: Lin TB, Hsieh MC, Lai CY, Cheng JK, Chau YP, Ruan T, Chen GD, Peng HY. Fbxo3-Dependent Fbxl2 Ubiquitination Mediates Neuropathic Allodynia through the TRAF2/TNIK/GluR1 Cascade. J Neurosci. 2015 Dec 16;35(50):16545-60. doi: 10.1523/JNEUROSCI.2301-15.2015. PMID: 26674878; PMCID: PMC6605509.